Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

Defining and measuring abstinence in clinical trials of smoking cessation interventions: An updated review.

Piper ME, Bullen C, Krishnan-Sarin S, Rigotti NA, Steinberg ML, Streck JM, Joseph AM.

Nicotine Tob Res. 2019 Jul 4. pii: ntz110. doi: 10.1093/ntr/ntz110. [Epub ahead of print]

PMID:
31271211
2.

Erratum: How Does Smoking and Nicotine Dependence Change After Onset of Vaping? A Retrospective Analysis of Dual Users.

Martínez Ú, Martínez-Loredo V, Simmons VN, Meltzer LR, Drobes DJ, Brandon KO, Palmer AM, Eissenberg T, Bullen CR, Harrell PT, Brandon TH.

Nicotine Tob Res. 2019 Jun 11. pii: ntz078. doi: 10.1093/ntr/ntz078. [Epub ahead of print] No abstract available.

PMID:
31184754
3.

Subcutaneous nicotine delivery via needle-free jet injection: A porcine model.

Ruddy BP, Bullen C, Chu JTW, Jeong SH, Madadkhahsalmassi B, McKeage JW, Svirskis D, Tingle MD, Xu J, Taberner AJ.

J Control Release. 2019 Jul 28;306:83-88. doi: 10.1016/j.jconrel.2019.05.040. Epub 2019 May 29.

PMID:
31150748
4.

Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.

Lindson N, Chepkin SC, Ye W, Fanshawe TR, Bullen C, Hartmann-Boyce J.

Cochrane Database Syst Rev. 2019 Apr 18;4:CD013308. doi: 10.1002/14651858.CD013308.

PMID:
30997928
5.

How Does Smoking and Nicotine Dependence Change after Onset of Vaping? A Retrospective Analysis of Dual Users.

Martínez Ú, Martínez-Loredo V, Simmons VN, Meltzer LR, Drobes DJ, Brandon KO, Palmer AM, Eissenberg T, Bullen CR, Harrell PT, Brandon TH.

Nicotine Tob Res. 2019 Mar 18. pii: ntz043. doi: 10.1093/ntr/ntz043. [Epub ahead of print]

PMID:
30883640
6.

Acute Effects of Heat-Not-Burn, Electronic Vaping, and Traditional Tobacco Combustion Cigarettes: The Sapienza University of Rome-Vascular Assessment of Proatherosclerotic Effects of Smoking ( SUR - VAPES ) 2 Randomized Trial.

Biondi-Zoccai G, Sciarretta S, Bullen C, Nocella C, Violi F, Loffredo L, Pignatelli P, Perri L, Peruzzi M, Marullo AGM, De Falco E, Chimenti I, Cammisotto V, Valenti V, Coluzzi F, Cavarretta E, Carrizzo A, Prati F, Carnevale R, Frati G.

J Am Heart Assoc. 2019 Mar 19;8(6):e010455. doi: 10.1161/JAHA.118.010455.

7.

Effectiveness and safety of nicotine patches combined with e-cigarettes (with and without nicotine) for smoking cessation: study protocol for a randomised controlled trial.

Walker N, Verbiest M, Kurdziel T, Laking G, Laugesen M, Parag V, Bullen C.

BMJ Open. 2019 Feb 25;9(2):e023659. doi: 10.1136/bmjopen-2018-023659.

8.

Correction: Socio-economic status and behavioural and cardiovascular risk factors in Papua New Guinea: A cross-sectional survey.

Rarau P, Pulford J, Gouda H, Phuanukoonnon S, Bullen C, Scragg R, Pham BN, McPake B, Oldenburg B.

PLoS One. 2019 Feb 20;14(2):e0212894. doi: 10.1371/journal.pone.0212894. eCollection 2019.

9.

Second-generation IL-2 receptor-targeted diphtheria fusion toxin exhibits antitumor activity and synergy with anti-PD-1 in melanoma.

Cheung LS, Fu J, Kumar P, Kumar A, Urbanowski ME, Ihms EA, Parveen S, Bullen CK, Patrick GJ, Harrison R, Murphy JR, Pardoll DM, Bishai WR.

Proc Natl Acad Sci U S A. 2019 Feb 19;116(8):3100-3105. doi: 10.1073/pnas.1815087116. Epub 2019 Feb 4.

PMID:
30718426
10.

Socio-economic status and behavioural and cardiovascular risk factors in Papua New Guinea: A cross-sectional survey.

Rarau P, Pulford J, Gouda H, Phuanukoonon S, Bullen C, Scragg R, Pham BN, McPake B, Oldenburg B.

PLoS One. 2019 Jan 23;14(1):e0211068. doi: 10.1371/journal.pone.0211068. eCollection 2019. Erratum in: PLoS One. 2019 Feb 20;14(2):e0212894.

11.

Vaping characteristics and expectancies are associated with smoking cessation propensity among dual users of combustible and electronic cigarettes.

Brandon KO, Simmons VN, Meltzer LR, Drobes DJ, Martínez Ú, Sutton SK, Palmer AM, Bullen CR, Harrell PT, Brandon TH.

Addiction. 2019 Jan 15. doi: 10.1111/add.14551. [Epub ahead of print]

PMID:
30644627
12.

Ascending single dose pharmacokinetics of cytisine in healthy adult smokers.

Jeong SH, Sheridan J, Bullen C, Newcombe D, Walker N, Tingle M.

Xenobiotica. 2019 Jun 19:1-6. doi: 10.1080/00498254.2018.1557760. [Epub ahead of print]

PMID:
30526213
13.

Evaluation of MyTeen - a SMS-based mobile intervention for parents of adolescents: a randomised controlled trial protocol.

Chu JTW, Whittaker R, Jiang Y, Wadham A, Stasiak K, Shepherd M, Bullen C.

BMC Public Health. 2018 Oct 26;18(1):1203. doi: 10.1186/s12889-018-6132-z.

14.

Measurement of electronic cigarette frequency of use among smokers participating in a randomized controlled trial.

Yingst J, Foulds J, Veldheer S, Cobb CO, Yen MS, Hrabovsky S, Allen SI, Bullen C, Eissenberg T.

Nicotine Tob Res. 2018 Oct 26. doi: 10.1093/ntr/nty233. [Epub ahead of print]

PMID:
30365024
15.

Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomized non-inferiority trial.

Walker N, Smith B, Barnes J, Verbiest M, Kurdziel T, Parag V, Pokhrel S, Bullen C.

Addiction. 2019 Feb;114(2):344-352. doi: 10.1111/add.14449. Epub 2018 Nov 9.

16.

Clarification on maternal alcohol consumption.

Bullen C.

N Z Med J. 2018 Sep 21;131(1482):94. No abstract available.

PMID:
30235200
17.

Impact of Tobacco Versus Electronic Cigarette Smoking on Platelet Function.

Nocella C, Biondi-Zoccai G, Sciarretta S, Peruzzi M, Pagano F, Loffredo L, Pignatelli P, Bullen C, Frati G, Carnevale R.

Am J Cardiol. 2018 Nov 1;122(9):1477-1481. doi: 10.1016/j.amjcard.2018.07.029. Epub 2018 Aug 3.

PMID:
30170691
18.

A Stability Indicating HPLC Method to Determine Actual Content and Stability of Nicotine within Electronic Cigarette Liquids.

Bansal M, Sharma M, Bullen C, Svirskis D.

Int J Environ Res Public Health. 2018 Aug 13;15(8). pii: E1737. doi: 10.3390/ijerph15081737.

19.

Alcohol consumption in New Zealand women before and during pregnancy: findings from the Growing Up in New Zealand study.

Rossen F, Newcombe D, Parag V, Underwood L, Marsh S, Berry S, Grant C, Morton S, Bullen C.

N Z Med J. 2018 Jul 27;131(1479):24-34.

PMID:
30048430
20.

Impact of venous leg ulceration on health-related quality of life: A synthesis of data from randomized controlled trials compared to population norms.

Jull A, Muchoney S, Parag V, Wadham A, Bullen C, Waters J.

Wound Repair Regen. 2018 Mar;26(2):206-212. doi: 10.1111/wrr.12636. Epub 2018 Jul 17.

PMID:
30015365
21.

Reaching cardiovascular prevention guideline targets with a polypill-based approach: a meta-analysis of randomised clinical trials.

Selak V, Webster R, Stepien S, Bullen C, Patel A, Thom S, Arroll B, Bots ML, Brown A, Crengle S, Dorairaj P, Elley CR, Grobbee DE, Harwood M, Hillis GS, Laba TL, Neal B, Peiris D, Rafter N, Reid C, Stanton A, Tonkin A, Usherwood T, Wadham A, Rodgers A.

Heart. 2019 Jan;105(1):42-48. doi: 10.1136/heartjnl-2018-313108. Epub 2018 Jun 28.

22.

Nicotine replacement therapy versus control for smoking cessation.

Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T.

Cochrane Database Syst Rev. 2018 May 31;5:CD000146. doi: 10.1002/14651858.CD000146.pub5. Review.

23.

The effectiveness and safety of combining varenicline with nicotine e-cigarettes for smoking cessation in people with mental illnesses and addictions: study protocol for a randomised-controlled trial.

Bullen C, Verbiest M, Galea-Singer S, Kurdziel T, Laking G, Newcombe D, Parag V, Walker N.

BMC Public Health. 2018 May 4;18(1):596. doi: 10.1186/s12889-018-5351-7.

24.

Free standing PEDOT films prepared by vapour phase polymerisation as electrically tuneable barriers to drug permeability.

Bansal M, Sharma M, Bullen C, Svirskis D.

Mater Sci Eng C Mater Biol Appl. 2018 Mar 1;84:248-253. doi: 10.1016/j.msec.2017.12.002. Epub 2017 Dec 14.

PMID:
29519436
25.

E-cigarette use in New Zealand-a systematic review and narrative synthesis.

Merry S, Bullen CR.

N Z Med J. 2018 Feb 23;131(1470):37-50.

PMID:
29470471
26.
27.

Predicting Short-Term Uptake of Electronic Cigarettes: Effects of Nicotine, Subjective Effects, and Simulated Demand.

Tucker MR, Laugesen M, Bullen C, Grace RC.

Nicotine Tob Res. 2018 Sep 4;20(10):1265-1271. doi: 10.1093/ntr/ntx269.

PMID:
29272446
28.

Prevalence of non-communicable disease risk factors in three sites across Papua New Guinea: a cross-sectional study.

Rarau P, Vengiau G, Gouda H, Phuanukoonon S, Kevau IH, Bullen C, Scragg R, Riley I, Marks G, Umezaki M, Morita A, Oldenburg B, McPake B, Pulford J.

BMJ Glob Health. 2017 Jun 14;2(2):e000221. doi: 10.1136/bmjgh-2016-000221. eCollection 2017.

29.

Low dose aspirin as adjuvant treatment for venous leg ulceration: pragmatic, randomised, double blind, placebo controlled trial (Aspirin4VLU).

Jull A, Wadham A, Bullen C, Parag V, Kerse N, Waters J.

BMJ. 2017 Nov 24;359:j5157. doi: 10.1136/bmj.j5157.

30.

Impact of switching to polypill based therapy by baseline potency of medication: Post-hoc analysis of the SPACE Collaboration dataset.

Webster R, Bullen C, Patel A, Selak V, Stepien S, Thom S, Rodgers A.

Int J Cardiol. 2017 Dec 15;249:443-447. doi: 10.1016/j.ijcard.2017.09.162. Epub 2017 Sep 20.

31.

Genome editing of human embryos: to edit or not to edit, that is the question.

Chandrasegaran S, Bullen CK, Carroll D.

J Clin Invest. 2017 Oct 2;127(10):3588-3590. doi: 10.1172/JCI96962. Epub 2017 Aug 28. Review. No abstract available.

32.

Rise in e-cigarette use linked to increase in smoking cessation rates.

Bullen C.

BMJ. 2017 Jul 26;358:j3506. doi: 10.1136/bmj.j3506. No abstract available.

PMID:
28747300
33.

Characterization of Elite Suppressors Cell-Associated HIV-1 mRNA at Baseline and with T Cell Activation

.

Pohlmyer CW, Bullen CK, Martin AR, Laird GM, Chioma SU, Walker-Sperling VEK, Blankson JN.

Yale J Biol Med. 2017 Jun 23;90(2):331-336. eCollection 2017 Jun.

34.

A randomized controlled trial of a smoking cessation self-help intervention for dual users of tobacco cigarettes and E-cigarettes: Intervention development and research design.

Meltzer LR, Simmons VN, Sutton SK, Drobes DJ, Quinn GP, Meade CD, Unrod M, Brandon KO, Harrell PT, Eissenberg T, Bullen CR, Brandon TH.

Contemp Clin Trials. 2017 Sep;60:56-62. doi: 10.1016/j.cct.2017.06.014. Epub 2017 Jun 22.

35.

The impact of a point-of-care testing device on CVD risk assessment completion in New Zealand primary-care practice: A cluster randomised controlled trial and qualitative investigation.

Wells S, Rafter N, Kenealy T, Herd G, Eggleton K, Lightfoot R, Arcus K, Wadham A, Jiang Y, Bullen C.

PLoS One. 2017 Apr 19;12(4):e0174504. doi: 10.1371/journal.pone.0174504. eCollection 2017.

36.

A Comparative Health Risk Assessment of Electronic Cigarettes and Conventional Cigarettes.

Chen J, Bullen C, Dirks K.

Int J Environ Res Public Health. 2017 Apr 5;14(4). pii: E382. doi: 10.3390/ijerph14040382.

37.

Economic evaluation of an exercise-counselling intervention to enhance smoking cessation outcomes: The Fit2Quit trial.

Leung W, Roberts V, Gordon LG, Bullen C, McRobbie H, Prapavessis H, Jiang Y, Maddison R.

Tob Induc Dis. 2017 Mar 29;15:21. doi: 10.1186/s12971-017-0126-y. eCollection 2017.

38.

Proposed new industry code on unhealthy food marketing to children and young people: will it make a difference?

Swinburn B, Vandevijvere S, Woodward A, Hornblow A, Richardson A, Burlingame B, Borman B, Taylor B, Breier B, Arroll B, Drummond B, Grant C, Bullen C, Wall C, Mhurchu CN, Cameron-Smith D, Menkes D, Murdoch D, Mangin D, Lennon D, Sarfati D, Sellman D, Rush E, Sopoaga F, Thomson G, Devlin G, Abel G, White H, Coad J, Hoek J, Connor J, Krebs J, Douwes J, Mann J, McCall J, Broughton J, Potter JD, Toop L, McCowan L, Signal L, Beckert L, Elwood M, Kruger M, Farella M, Baker M, Keall M, Skeaff M, Thomson M, Wilson N, Chandler N, Reid P, Priest P, Brunton P, Crampton P, Davis P, Gendall P, Howden-Chapman P, Taylor R, Edwards R, Beaglehole R, Doughty R, Scragg R, Gauld R, McGee R, Jackson R, Hughes R, Mulder R, Bonita R, Kruger R, Casswell S, Derrett S, Ameratunga S, Denny S, Hales S, Pullon S, Wells S, Cundy T, Blakely T.

N Z Med J. 2017 Feb 17;130(1450):94-101.

PMID:
28207729
39.

E-cigarettes and Urologic Health: A Collaborative Review of Toxicology, Epidemiology, and Potential Risks.

Bourke L, Bauld L, Bullen C, Cumberbatch M, Giovannucci E, Islami F, McRobbie H, Silverman DT, Catto JWF.

Eur Urol. 2017 Jun;71(6):915-923. doi: 10.1016/j.eururo.2016.12.022. Epub 2017 Jan 7. Review.

PMID:
28073600
40.

Reducing the nicotine content of combusted tobacco products sold in New Zealand.

Donny EC, Walker N, Hatsukami D, Bullen C.

Tob Control. 2017 Mar;26(e1):e37-e42. doi: 10.1136/tobaccocontrol-2016-053186. Epub 2016 Sep 26.

PMID:
27672126
41.

Parental smoking during pregnancy: findings from the Growing Up in New Zealand cohort.

Humphrey G, Rossen F, Walker N, Bullen C.

N Z Med J. 2016 Sep 23;129(1442):60-74.

PMID:
27657160
42.

Electronic cigarettes for smoking cessation.

Hartmann-Boyce J, McRobbie H, Bullen C, Begh R, Stead LF, Hajek P.

Cochrane Database Syst Rev. 2016 Sep 14;9:CD010216. doi: 10.1002/14651858.CD010216.pub3. Review.

43.
44.

E-cigarettes for the management of nicotine addiction.

Knight-West O, Bullen C.

Subst Abuse Rehabil. 2016 Aug 18;7:111-8. doi: 10.2147/SAR.S94264. eCollection 2016. Review.

45.

Making the next steps the right ones: progress towards the Smokefree Aotearoa 2025 Goal.

McCool J, Bullen C.

N Z Med J. 2016 Aug 5;129(1439):6-7. No abstract available.

PMID:
27507716
46.

Using run charts for cardiovascular disease risk assessments in general practice.

Wells S, Rafter N, Eggleton K, Turner C, Huang Y, Bullen C.

J Prim Health Care. 2016 Jun;8(2):172-8. doi: 10.1071/HC15030.

PMID:
27477560
47.

Getting cytisine licensed for use world-wide: a call to action.

Walker N, Bullen C, Barnes J, McRobbie H, Tutka P, Raw M, Etter JF, Siddiqi K, Courtney RJ, Castaldelli-Maia JM, Selby P, Sheridan J, Rigotti NA.

Addiction. 2016 Nov;111(11):1895-1898. doi: 10.1111/add.13464. Epub 2016 Jul 17. No abstract available.

PMID:
27426482
48.

Dispensing data captures individual-level use of aspirin for cardiovascular disease prevention, despite availability over-the-counter.

Selak V, Gu Y, Rafter N, Crengle S, Kerr AJ, Bullen C.

N Z Med J. 2016 May 27;129(1435):21-8.

PMID:
27355165
49.

CLINICAL DECISIONS. E-Cigarettes and Smoking Cessation.

Yeh JS, Bullen C, Glantz SA.

N Engl J Med. 2016 Jun 2;374(22):2172-4. doi: 10.1056/NEJMclde1602420. No abstract available.

PMID:
27248625
50.

E-cigarettes and smoking cessation.

Hajek P, McRobbie H, Bullen C.

Lancet Respir Med. 2016 Jun;4(6):e23. doi: 10.1016/S2213-2600(16)30024-8. Epub 2016 Apr 25. No abstract available.

PMID:
27133216

Supplemental Content

Loading ...
Support Center